Cambridge Catalogue  
  • Help
Home > Catalogue > Valuing Health Care
Valuing Health Care
Google Book Search

Search this book


  • 39 b/w illus. 15 tables
  • Page extent: 288 pages
  • Size: 228 x 152 mm
  • Weight: 0.4 kg


 (ISBN-13: 9780521576468 | ISBN-10: 0521576466)

As expenditure on health care has increasingly become an area of public debate and concern, public and private health care decision-makers have called for more rigorous use of cost-benefit and cost-effectiveness analysis to guide spending. Concerns have arisen, however, about the overall quality of such analyses. This book discusses and evaluates best-practice methods of conducting cost-benefit and cost-effectiveness studies of pharmaceuticals and other medical technologies. It encompasses a wide variety of topics, ranging from measuring cost and effectiveness to discounting to the use of dynamic modelling of cost-effectiveness. The book also includes conceptual and practical aspects of cost-effectiveness analysis by researchers who have conducted applied research in these areas. Rarely does the book provide a singular solution to a measurement problem; rather, the reader is directed to choices among alternative approaches and an analysis of the advantages and disadvantages of each.

• Offers unique coverage of such issues as: relative merits of cost-effectiveness analysis versus cost-benefit analysis, discounting, use of observational data versus experimental evidence in cost-effectiveness analysis • Controversial and highly topical subject • Successful when published in paperback


1. Introduction Frank A. Sloan; 2. Evidence of effectiveness: evaluating its quality Allan S. Detsky; 3. Utility assessment for estimating quality-adjusted life years Robert M. Kaplan; 4. Measuring costs David Dranove; 5. From cost-effectiveness ratios to resource allocation: where to draw the line? Milton C. Weinstein; 6. Valuing health care benefits in money terms Mark V. Pauly; 7. Discounting health effects for medical decisions W. Kip Viscusi; 8. Statistical issues in cost-effectiveness analyses John Mullahy and Willard Manning; 9. Decision trees and Markov models in cost-effectiveness research Emmett Keeler; 10. Alternative methods of allocating health resources under constraints Frank A. Sloan and Christopher J. Conover.


'A fine set of papers by superb authors who well describe the current state-of-the-art in cost benefit and cost effectiveness analysis.' Joseph P. Newhouse, Harvard University


Frank A. Sloan, Allan S. Detsky, Robert M. Kaplan, David Dranove, Milton C. Weinstein, Mark V. Pauly, W. Kip Viscusi, John Mullahy, Willard Manning, Emmett Keeler, Christopher J. Conover

printer iconPrinter friendly version AddThis